BioLineRx (BLRX) Minority Interest (2025 - 2026)
BioLineRx (BLRX) posted quarterly Minority Interest of $5.1 million for Q4 2025.
Powered by 
Analysis
BioLineRx (BLRX) Minority Interest (2025 - 2026) Analysis & Trends
BioLineRx's Minority Interest history runs 1 years deep, the most recent figure standing at $5.1 million for Q4 2025.
- In Q4 2025, Minority Interest changed N/A year-over-year to $5.1 million; the TTM figure through Dec 2025 stood at $5.1 million (changed N/A YoY), while the FY2025 annual figure was $5.1 million, changed N/A from the prior year.
- Minority Interest for Q4 2025 stood at $5.1 million.
- The five-year high for Minority Interest was $5.1 million in Q4 2025, with the low at $5.1 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | BioLineRx | 6.64 Bn | 6.64 Bn | 235,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.85 Mn |
| Mar 31, 2026 | 4.16 Mn |
| Dec 31, 2025 | 5.15 Mn |